Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: Effects of intrauterine levonorgestrel

Molecular Human Reproduction

Volumn 6, Issue 11, 2000, Pages 1013-1018

  Hurskainen, R ^a,b,c   Salmi, A ^a   Paavonen, J ^a   Teperi, J ^b   Rutanen, E M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NONE   (Finland)

Author keywords

Endometrium; Ki 67; Levonorgestrel releasing IUS; Menorrhagia; Sex steroid receptors

Indexed keywords

LEVONORGESTREL; SEX HORMONE; STEROID RECEPTOR;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MENORRHAGIA; MENSTRUATION; PRIORITY JOURNAL;

EID: 0033724720     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/6.11.1013     Document Type: Article

References (29)

1. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia
2. Monoclonal antibodies to human progesterone receptor: Characterization by biochemical and immunohistochemical techniques
3. General practitioners' referrals to specialist outpatient clinics
4. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle
5. Endometrial sex steroid receptor expression in women with menorrhagia
6. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery
7. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system
8. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine
9. Cyclical variation in endometrial oestrogen and progesterone receptors in women with normal menstruation and dysfunctional uterine bleeding
10. Determination of menstrual blood loss
11. Risk-benefit assessment of drugs used for the treatment of menstrual disorders
12. Combined laboratory and diary method for objective assessment of menstrual blood loss
13. Comparison of the ligand-binding specificity and transcript tissue distribution of estrogen receptors α and β
14. Progestogen-only pills and bleeding disturbances
15. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle
16. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties
17. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia
18. Erβ: Identification and characterization of a novel human oestrogen receptor
19. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD
20. Dating the endometrial biopsy
21. Menorrhagia
22. Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein
23. Decidual transformation of human extrauterine mesenchymal cells is associated with the appearance of insulin-like growth factor binding protein-1
24. mRNA expression of insulin-like growth factor (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during the use of an intrauterine levonorgestrel system
25. Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: Relationship to oestrogen receptor status
26. The effect of intrauterine levonorgestrel use on the expression of C-Jun, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium
27. Cellular localization of c-jun messenger ribonucleic acid and protein and their relation to the proliferation marker Ki-67 in the human endometrium
28. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices
29. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause